Novoprotein Scientific Inc. (SHA:688137)
China
· Delayed Price · Currency is CNY 43.10
+2.05 (4.99%)
At close: Mar 10, 2026
Novoprotein Scientific Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Market Capitalization | 2,864 | 2,794 | 2,318 | 3,893 | 5,333 | - | Upgrade
|
| Market Cap Growth | 22.04% | 20.54% | -40.46% | -27.00% | - | - | Upgrade
|
| Enterprise Value | 2,113 | 2,044 | 1,723 | 2,059 | 3,483 | - | Upgrade
|
| Last Close Price | 41.05 | 40.05 | 33.20 | 54.59 | 74.04 | - | Upgrade
|
| PE Ratio | - | - | - | 303.14 | 58.79 | - | Upgrade
|
| PS Ratio | 18.90 | 18.44 | 18.17 | 25.42 | 20.16 | - | Upgrade
|
| PB Ratio | 1.38 | 1.34 | 1.10 | 1.78 | 2.42 | - | Upgrade
|
| P/TBV Ratio | 1.39 | 1.36 | 1.11 | 1.79 | 2.44 | - | Upgrade
|
| P/FCF Ratio | - | - | - | 160.75 | - | - | Upgrade
|
| P/OCF Ratio | - | - | 174.09 | 56.30 | 1579.48 | - | Upgrade
|
| EV/Sales Ratio | 13.95 | 13.49 | 13.51 | 13.44 | 13.17 | - | Upgrade
|
| EV/EBITDA Ratio | - | - | - | - | 38.49 | - | Upgrade
|
| EV/EBIT Ratio | - | - | - | - | 42.49 | - | Upgrade
|
| EV/FCF Ratio | - | - | - | 84.99 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.02 | 0.03 | 0.03 | 0.04 | 0.24 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | - | 0.81 | 0.47 | Upgrade
|
| Debt / FCF Ratio | - | - | - | 3.03 | - | 85.69 | Upgrade
|
| Net Debt / Equity Ratio | -0.36 | -0.36 | -0.82 | -0.83 | -0.82 | -0.28 | Upgrade
|
| Net Debt / EBITDA Ratio | 13.32 | 13.32 | 19.61 | 46.45 | -20.04 | -0.57 | Upgrade
|
| Net Debt / FCF Ratio | - | - | 54.96 | -75.00 | 54.32 | -100.78 | Upgrade
|
| Asset Turnover | - | - | 0.06 | 0.07 | 0.19 | 1.00 | Upgrade
|
| Inventory Turnover | - | - | 0.91 | 0.87 | 0.95 | 1.95 | Upgrade
|
| Quick Ratio | - | - | 27.90 | 39.37 | 31.89 | 4.03 | Upgrade
|
| Current Ratio | - | - | 29.13 | 41.30 | 33.35 | 4.63 | Upgrade
|
| Return on Equity (ROE) | -3.64% | -3.64% | -2.54% | 0.58% | 7.09% | 64.38% | Upgrade
|
| Return on Assets (ROA) | - | - | -2.78% | -1.33% | 3.60% | 32.15% | Upgrade
|
| Return on Invested Capital (ROIC) | -5.13% | -8.04% | -27.16% | -12.98% | 21.75% | 84.22% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | -4.70% | -2.20% | 3.60% | 39.90% | Upgrade
|
| Earnings Yield | -2.66% | -2.73% | -2.35% | 0.33% | 1.70% | - | Upgrade
|
| FCF Yield | - | - | -1.36% | 0.62% | -0.63% | - | Upgrade
|
| Dividend Yield | - | - | - | 0.92% | 0.68% | - | Upgrade
|
| Payout Ratio | - | - | - | 273.19% | - | 10.93% | Upgrade
|
| Buyback Yield / Dilution | -0.18% | -0.18% | 2.23% | -25.05% | -42.83% | -151.52% | Upgrade
|
| Total Shareholder Return | -0.18% | -0.18% | 2.23% | -24.14% | -42.16% | -151.52% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.